ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo aims to halt prostate cancer in its tracks
Disease control Not yet recruitingThis study tests a new vaccine (TriAdeno) plus a drug (N-803) in 52 men with early-stage prostate cancer who are currently under active surveillance. The goal is to see if this combination can boost the immune system to attack the tumor and prevent it from growing. Participants r…
Matched conditions: ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Promising new combo aims to slow stomach cancer progression
Disease control Not yet recruitingThis study tests whether a new drug (tecotabart vedotin) combined with tislelizumab works better than standard chemotherapy plus tislelizumab for people with advanced stomach or gastroesophageal junction cancer that has a specific marker (CLDN18.2). About 752 adults who have not …
Matched conditions: ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:13 UTC